What is new in point-of-care testing?

Point of Care

Volumn 8, Issue 4, 2009, Pages 166-170

  Melanson, Stacy E F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acquired immunodeficiency syndrome, HIV; Acute coronary syndrome; Coagulation; Diabetes; Glucose; Hemostasis; INR; Platelet function; Point of care testing; Troponin

Indexed keywords

EID: 73949101937     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e3181c557ec     Document Type: Review

References (55)

1. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
2. Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, et al. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med. 2008;36:3062-3066.
3. Shearer A, Boehmer M, Closs M, et al. Comparison of glucose point-of-care values with laboratory values in critically ill patients. Am J Crit Care. 2009;18:224-230.
4. Rush E, Crook N, Simmons D. Point-of-care testing as a tool for screening for diabetes and pre-diabetes. Diabet Med. 2008;25:1070-1075.
5. Kost GJ, Tran NK, Louie RF, et al. Assessing the performance of handheld glucose testing for critical care. Diabetes Technol Ther. 2008;10:445-451.
6. Eastham JH, Mason D, Barnes DL, et al. Prevalence of interfering substances with point-of-care glucose testing in a community hospital. Am J Health Syst Pharm. 2009;66:167-170.
7. Christenson RH, Azzazy HM. Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms. Clin Biochem. 2009;42:150-157.
8. Friess U, Stark M. Cardiac markers: a clear cause for point-of-care testing. Anal Bioanal Chem. 2009;393:1453-1462.
9. Bock JL, Singer AJ, Thode HC Jr. Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I. Am J Clin Pathol. 2008;130:132-135.
10. Straface AL, Myers JH, Kirchick HJ, et al. A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. Am J Clin Pathol. 2008;129:788-795.
11. Pernet P, Beneteau-Burnat B, Hermand C, et al. Point-of-care testing: false elevation of cardiac troponin I assayed in the emergency department. Am J Emerg Med. 2008;26:969 e1-e2.
12. Fuller F. Just point and click. Is your system ready for point-of-care testing? EMS Mag. 2008;37:84-89.
13. Ryan RJ, Lindsell CJ, Hollander JE, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. Ann Emerg Med. 2009;53:321-328.
14. Barcellona D, Fenu L, Cornacchini S, et al. Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? Thromb Res. 2009;123:775-779.
15. Plesch W, van den Besselaar AM. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol. 2009;31:20-25.
16. Plesch W, Wolf T, Breitenbeck N, et al. Results of the performance verification of the CoaguChek XS system. Thromb Res. 2008;123:381-389.
17. Maddox JM, Bogo PH, McGregor E, et al. Quality assurance for point-of-care testing of oral anticoagulation: a large-scale evaluation of the Hemochron Junior Signature Microcoagulation System. Int J Lab Hematol. 2009;31:142-150.
18. Green TL, Mansoor A, Newcommon N, et al. Reliability of point-of-care testing of INR in acute stroke. Can J Neurol Sci. 2008;35:348-351.
19. Kong MC, Lim TG, Ng HJ, et al. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Ann Hematol. 2008;87:905-910.
20. van den Besselaar AM, Witteveen E, van der Meer FJ. Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma. Thromb Haemost. 2008;100:1181-1184.
21. Hoel RW, Albright RC, Beyer LK, et al. Correlation of point-of-care international normalized ratio to laboratory international normalized ratio in hemodialysis patients taking warfarin. Clin J Am Soc Nephrol. 2009;4:99-104.
22. Toulon P, Ozier Y, Ankri A, et al. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost. 2009;101:394-401.
23. Douglas AD, Jefferis J, Sharma R, et al. Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin. Angiology. 2009;60:358-361.
24. Appiah LT, Havers F, Gibson J, et al. Efficacy and acceptability of rapid, point-of-care HIV testing in two clinical settings in Ghana. AIDS Patient Care STDS. 2009;23:365-369.
25. Pai NP, Barick R, Tulsky JP, et al. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med. 2008;5:e92.
26. Bogart LM, Howerton D, Lange J, et al. Scope of rapid HIV testing in urban U.S. hospitals. Public Health Rep. 2008;123:494-503.
27. Forsyth SF, Agogo EA, Lau L, et al. Would offering rapid point-of-care testing or non-invasive methods improve uptake of HIV testing among high-risk genitourinary medicine clinic attendees? A patient perspective. Int J STD AIDS. 2008;19:550-552.
28. Knapp H, Anaya HD, Feld JE. Expanding HIV rapid testing via point-of-care paraprofessionals. Int J STD AIDS. 2008;19:629-632.
29. Surah S, O'Shea S, Dunn H, et al. Utilization of HIV point-of-care testing clinics in general practice and genitourinary medicine services in south-east London. Int J STD AIDS. 2009;20:168-169.
30. Dickinson KJ, Troxler M, Homer-Vanniasinkam S. The surgical application of point-of-care haemostasis and platelet function testing. Br J Surg. 2008;95:1317-1330.
31. Velik-Salchner C, Maier S, Innerhofer P, et al. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg. 2008;107:1798-1806.
32. Pinto Slottow TL, Bonello L, Gavini R, et al. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis. Am J Cardiol. 2009;104:525-530.
33. Price MJ, Endemann S, Gollapudi RR, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J. 2008;29:992-1000.
34. Lordkipanidze M, Pharand C, Nguyen TA, et al. Assessment of VerifyNow P2-12 assay accuracy in evaluating clopidogrel-induced platelet inhibition. Ther Drug Monit. 2008;30:372-378.
35. Carceller-Blanchard A, Cousineau J, Delvin EE. Point of care testing: transcutaneous bilirubinometry in neonates. Clin Biochem. 2009;42:143-149.
36. Charles PG. Early diagnosis of lower respiratory tract infections (point-of-care tests). Curr Opin Pulm Med. 2008;14:176-182.
37. Pfafflin A, Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem. 2009;393:1473-1480.
38. Warsinke A. Point-of-care testing of proteins. Anal Bioanal Chem. 2009;393:1393-1405.
39. Hatchette TF, Bastien N, Berry J, et al. The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know. Can J Public Health. 2009;100:204-207.
40. Benzaken AS, Sabido M, Galban EG, et al. Field evaluation of the performance and testing costs of a rapid point-of-care test for syphilis in a red-light district of Manaus, Brazil. Sex Transm Infect. 2008;84:297-302.
41. Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis. 2008;35:775-784.
42. Sabido M, Benzaken AS, de-Andrade-Rodrigues EJ, et al. Rapid point-of-care diagnostic test for syphilis in high-risk populations, Manaus, Brazil. Emerg Infect Dis. 2009;15:647-649.
43. Leyland B, Kennedy MR, Wimberly YH, et al. Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from focus diagnostics. J Clin Virol. 2009;44:125-128.
44. Nissinen A, Stranden P, Myllys R, et al. Point-of-care testing of group A streptococcal antigen: performance evaluated by external quality assessment. Eur J Clin Microbiol Infect Dis. 2009;28:17-20.
45. Cals JW, Butler CC, Hopstaken RM, et al. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009;338:b1374.
46. Ratnawati, Hatta M, Smits HL. Point-of-care testing for malaria outbreak management. Trans R Soc Trop Med Hyg. 2008;102: 699-704.
47. Lewandrowski K, Flood J, Finn C, et al. Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay. Am J Clin Pathol. 2008;129:796-801.
48. Shaikh S, Hull MJ, Bishop KA, et al. Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine. J Anal Toxicol. 2008;32:339-343.
49. Briggs C, Carter J, Lee SH, et al. ICSH Guideline for worldwide point-of-care testing in haematology with special reference to the complete blood count. Int J Lab Hematol. 2008;30:105-116.
50. Briggs C, Guthrie D, Hyde K, et al. Guidelines for point-of-care testing: haematology. Br J Haematol. 2008;142:904-915.
51. Gupta A, Wrench IJ, Feast MJ, et al. Use of the HemoCue near patient testing device to measure the concentration of haemoglobin in suction fluid at elective caesarean section. Anaesthesia. 2008; 63:531-534.
52. Dale RA, Jensen LH, Krantz MJ. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Ann Pharmacother. 2008;42:633-639.
53. Rapi S, Bazzini C, Tozzetti C, et al. Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system. Transl Res. 2009;153:71-76.
54. Cole LA, Ladner DG. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests. Clin Biochem. 2009;42:168-175.
55. Lambers Heerspink HJ, Witte EC, Bakker SJ, et al. Screening and monitoring for albuminuria: the performance of the HemoCue point-of-care system. Kidney Int. 2008;74:377-383.